Canine Cancer

Click here for more information on our May 2022 Canine Cancer Webinar Series

PCAM

AKC Canine Health Foundation Canine Cancer Research

Since 1995, CHF and its donors have funded over $17 million in canine cancer research. These 257 research grants have helped scientists study cancer at the cellular level, providing breakthroughs that allow veterinarians to diagnose cancer earlier and treat it more effectively. CHF-funded research also has a One Health impact, extending beyond dogs with an application to human cancer diagnosis and treatment.

Canine cancer research is a major concern of dog owners and veterinary professionals. Typically, about one quarter of CHF’s grant funding concerns various types of canine cancers.

View our Cancer Research Portfolio

Resources

Canine Cancer Articles 

A Gene Therapy Clinical Trial for Dogs with Glioma September 12, 2011

Researchers at the University of Minnesota are currently conducting clinical trials to find new and better ways to treat gliomas. In the past 12 months, they have recruited 10 dogs for a gene therapy study. Preliminary data hint at improved times of progression-free as well as overall survival in dogs treated with gene therapy.

Pilot study assesses feasibility of tissue collections and molecular profiling for personalized medicine studies August 24, 2011

Personalized medicine involves tailoring cancer treatment and prevention to the specific molecular nature of the individual and their cancer. The hope is that targeted therapies will be more effective with less risk for the patient than traditional treatments.

Using Technology to Target Tumors February 25, 2011

Dr. Nicola Mason and her colleagues at the University of Pennsylvania, with the support of the AKC Canine Health Foundation, have been trying to find new ways to use antibody fragments to target a particularly devastating type of canine tumor. They are looking for a more effective treatment for canine hemangiosarcoma.

Malignant Histiocytosis: Looking for a Cure December 1, 2010

The median survival time for malignant histiocytosis is only 2-4 months. Traditional cancer treatments such as radiation and surgery are generally ineffective in dogs with MH. There is hope for the future; however, as preliminary studies of a new form of treatment have shown some real promise.

Personalizing Cancer September 4, 2010

With a $12,000, start-up grant from the AKC Canine Health Foundation, researchers at Van Andel Research Institute soon identified regions of DNA associated with hemangiosarcoma in Clumber Spaniels. Little did they know that their project would become part of a larger effort involving academic, industry and government organizations and that it would result in a revolutionary move to provide better cancer treatment not only for dogs but for people, too.

Items 46 - 50 of 59  Previous12345678910Next

 

Resources Available for Download



Webinars

 May 2022 Canine Cancer Webinar Series
Join us for a series of pre-recorded and live webinars on canine cancer. Registration is FREE during Pet Cancer Awareness Month – May 2022. After that, a recording of the entire series will be available on a pay per view basis through the AKC Canine College.

May 5, 2022 @ 7pm ET: Predicting Lymphoma in Dogs
Presented by Dr. Daniel Promislow

May 12, 2022 @ 7pm ET: Luteinizing Hormone Receptor Activation in Lymphoma and Hemangiosarcoma
Presented by Dr. Michelle Kutzler

May 19, 2022 @ 7pm ET: Toward Curative Outcomes in Canine Hemangiosarcoma
Presented by Dr. Chand Khanna

May 26, 2022 @ 7pm ET: LIVE Panel Q&A Session
Presented by Drs. Promislow, Kutzler, and Khanna


A Novel Non-Surgical Option to Preserve Limbs in Canine Osteosarcoma
Original air date: May 25, 2021
Speaker: Joanne Tuohy, DVM, PhD, DACVS

Recent Advances in Cancer Immunotherapy
Original air date: May 2020
Speaker: Steven Dow, DVM, PhD, Diplomate ACVIM (Oncology)

Update on Canine Hemangiosarcoma
Original air date: May 2017
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)

Cancer Immunotherapy: Basic Concepts and Strategies for Improving Treatment Outcomes
Original air date: October 2016
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)

Lymphoma: The State of This Disease in Dogs and How Epigenetics May Open Future Doors
Original air date: June 2016
Speaker: Jeffrey M. Bryan, DVM, MS, PhD, DACVIM (Oncology)


Podcasts

The Dog Cancer Answers podcast spoke with AKC Chief Veterinary Officer Dr. Jerry Klein about How to Choose a Dog Breeder. Listen for ways to increase the odds of having a healthy puppy, including the importance of AKC Canine Health Foundation funded research.

How You Can Help

Your support means more studies exploring improved diagnostics and new treatment strategies for canine cancer.


img14

Donate to Support Canine Cancer Research

Support Now!

View more

Participate in Research

Learn how you and your dog can help canine health researchers!

View more
PCAM - Small

Sponsor Canine Cancer Research

Sponsor today at a $2,500+ level!

View more

 

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617
(888)-682-9696

Tax ID# 13-3813813

   2020 GuideStar logo

© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.